AAAAAA

   
Results: 1-25 | 26-50 | 51-67
Results: 1-25/67

Authors: SORDET F AUMJAUD Y FESSI H DEROUIN F
Citation: F. Sordet et al., ASSESSMENT OF THE ACTIVITY OF ATOVAQUONE-LOADED NANOCAPSULES IN THE TREATMENT OF ACUTE AND CHRONIC MURINE TOXOPLASMOSIS, Parasite, 5(3), 1998, pp. 223-229

Authors: DEROUIN F GERARD L FARINOTTI R MASLO C LEPORT C
Citation: F. Derouin et al., DETERMINATION OF THE INHIBITORY EFFECT ON TOXOPLASMA GROWTH IN THE SERUM OF AIDS PATIENTS DURING ACUTE THERAPY FOR TOXOPLASMIC ENCEPHALITIS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(1), 1998, pp. 50-54

Authors: HONORE S GARIN YJF SULAHIAN A GANGNEUX JP DEROUIN F
Citation: S. Honore et al., INFLUENCE OF THE HOST AND PARASITE STRAIN IN A MOUSE MODEL OF VISCERAL LEISHMANIA-INFANTUM INFECTION, FEMS immunology and medical microbiology, 21(3), 1998, pp. 231-239

Authors: LIGUORY O DAVID F SARFATI C DEROUIN F MOLINA JM
Citation: O. Liguory et al., DETERMINATION OF TYPES OF ENTEROCYTOZOON-BIENEUSI STRAINS ISOLATED FROM PATIENTS WITH INTESTINAL MICROSPORIDIOSIS, Journal of clinical microbiology, 36(7), 1998, pp. 1882-1885

Authors: BRUNPASCAUD M RAJAGOPALANLEVASSEUR P CHAU F BERTRAND G GARRY L DEROUIN F GIRARD PM
Citation: M. Brunpascaud et al., DRUG-EVALUATION OF CONCURRENT PNEUMOCYSTIS-CARINII, TOXOPLASMA-GONDII, AND MYCOBACTERIUM-AVIUM COMPLEX INFECTIONS IN A RAT MODEL, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1068-1072

Authors: HUTIN YJF SOMBARDIER MN LIGUORY O SARFATI C DEROUIN F MODAI J MOLINA JM
Citation: Yjf. Hutin et al., RISK-FACTORS FOR INTESTINAL MICROSPORIDIOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A CASE-CONTROL STUDY, The Journal of infectious diseases, 178(3), 1998, pp. 904-907

Authors: MOLINA JM CHASTANG C GOGUEL J MICHIELS JF SARFATI C DESPORTESLIVAGE I HORTON J DEROUIN F MODAI J
Citation: Jm. Molina et al., ALBENDAZOLE FOR TREATMENT AND PROPHYLAXIS OF MICROSPORIDIOSIS DUE TO ENCEPHALITOZOON INTESTINALIS IN PATIENTS WITH AIDS - A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL, The Journal of infectious diseases, 177(5), 1998, pp. 1373-1377

Authors: SPARFEL JM SARFATI C LIGUORY O CAROFF B DUMOUTIER N GUEGLIO B BILLAUD E RAFFI F MOLINA JM MIEGEVILLE M DEROUIN F
Citation: Jm. Sparfel et al., DETECTION OF MICROSPORIDIA AND IDENTIFICATION OF ENTEROCYTOZOON-BIENEUSI IN SURFACE-WATER BY FILTRATION FOLLOWED BY SPECIFIC PCR, The Journal of eukaryotic microbiology, 44(6), 1997, pp. 78-78

Authors: SULAHIAN A GARIN YJF PRATLONG F DEDET JP DEROUIN F
Citation: A. Sulahian et al., EXPERIMENTAL PATHOGENICITY OF VISCEROTROPIC AND DERMOTROPIC ISOLATES OF LEISHMANIA-INFANTUM FROM IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS IN A MURINE MODEL, FEMS immunology and medical microbiology, 17(3), 1997, pp. 131-138

Authors: LIGUORY O DAVID F SARFATI C DEROUIN F MODAI J MOLINA JM
Citation: O. Liguory et al., PCR (POLYMERASE CHAIN-REACTION) DIAGNOSIS AND SPECIES IDENTIFICATION OF INTESTINAL MICROSPORIDIA SPECIMENS FROM HIV-INFECTED PATIENTS, Medecine et maladies infectieuses, 27, 1997, pp. 994-999

Authors: DALENCON F AMJAUD Y LAFFORGUE C DEROUIN F FESSI H
Citation: F. Dalencon et al., ATOVAQUONE AND RIFABUTINE-LOADED NANOCAPSULES - FORMULATION STUDIES, International journal of pharmaceutics, 153(1), 1997, pp. 127-130

Authors: GARIN YJF SULAHIAN A GANGNEUX JP DEROUIN F
Citation: Yjf. Garin et al., ACTIVITY OF IFN-GAMMA IN EXPERIMENTAL LEISHMANIA-INFANTUM MURINE VISCERAL LEISHMANIASIS, Pathologie et biologie, 45(1), 1997, pp. 48-51

Authors: GANGNEUX JP SULAHIAN A GARIN YJF DEROUIN F
Citation: Jp. Gangneux et al., EFFICACY OF AMINOSIDINE ADMINISTERED ALONE OR IN COMBINATION WITH MEGLUMINE ANTIMONIATE FOR THE TREATMENT OF EXPERIMENTAL VISCERAL LEISHMANIASIS CAUSED BY LEISHMANIA-INFANTUM, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 287-289

Authors: LIGUORY O DAVID F SARFATI C SCHUITEMA ARJ HARTSKEERL RA DEROUIN F MODAI J MOLINA JM
Citation: O. Liguory et al., DIAGNOSIS OF INFECTIONS CAUSED BY ENTEROCYTOZOON-BIENEUSI AND ENCEPHALITOZOON INTESTINALIS USING POLYMERASE CHAIN-REACTION IN STOOL SPECIMENS, AIDS, 11(6), 1997, pp. 723-726

Authors: PELLOUX H DUPOUYCAMET J DEROUIN F ABOULKER JP RAFFI F
Citation: H. Pelloux et al., A MULTICENTER PROSPECTIVE-STUDY FOR THE POLYMERASE CHAIN-REACTION DETECTION OF TOXOPLASMA-GONDII DNA IN BLOOD-SAMPLES FROM 186 AIDS PATIENTS WITH SUSPECTED TOXOPLASMIC ENCEPHALITIS, AIDS, 11(15), 1997, pp. 1888-1890

Authors: MOLINA JM GOGUEL J SARFATI C CHASTANG C DESPORTESLIVAGE I MICHIELS JF MASLO C KATLAMA C COTTE L LEPORT C RAFFI F DEROUIN F MODAI J
Citation: Jm. Molina et al., POTENTIAL EFFICACY OF FUMAGILLIN IN INTESTINAL MICROSPORIDIOSIS DUE TO ENTEROCYTOZOON-BIENEUSI IN PATIENTS WITH HIV-INFECTION - RESULTS OF A DRUG SCREENING STUDY, AIDS, 11(13), 1997, pp. 1603-1610

Authors: HOWE DK HONORE S DEROUIN F SIBLEY LD
Citation: Dk. Howe et al., DETERMINATION OF GENOTYPES OF TOXOPLASMA-GONDII STRAINS ISOLATED FROMPATIENTS WITH TOXOPLASMOSIS, Journal of clinical microbiology, 35(6), 1997, pp. 1411-1414

Authors: VANGOOL T VETTER JCM WEINMAYR B VANDAM A DEROUIN F DANKERT J
Citation: T. Vangool et al., HIGH SEROPREVALENCE OF ENCEPHALITOZOON SPECIES IN IMMUNOCOMPETENT SUBJECTS, The Journal of infectious diseases, 175(4), 1997, pp. 1020-1024

Authors: LACROIX C CHAU F CARBON C SINET M DEROUIN F
Citation: C. Lacroix et al., CRYPTOCOCCUS-NEOFORMANS INFECTION IN MICE PREVIOUSLY INFECTED WITH LP-BM5 MULV, THE AGENT OF MURINE AIDS (MAIDS), Clinical and experimental immunology, 110(2), 1997, pp. 196-202

Authors: BRUNPASCAUD M CHAU F DEROUIN F GIRARD PM
Citation: M. Brunpascaud et al., LACK OF ACTIVITY OF ARTEMETHER FOR PROPHYLAXIS AND TREATMENT OF TOXOPLASMA-GONDII AND PNEUMOCYSTIS-CARINII INFECTIONS IN RAT, Parasite, 3(2), 1996, pp. 187-189

Authors: SORIAROYER C BOUGNOUX ME SULAHIAN A RIBAUD P TRAORE F GARIN YJF GLUCKMAN E DEROUIN F
Citation: C. Soriaroyer et al., RAPD TYPING OF ASPERGILLUS-FUMIGATUS STRA INS - EPIDEMIOLOGIC APPLICATIONS ON A HOSPITAL SITE, Journal de mycologie medicale, 6(2), 1996, pp. 49-55

Authors: BRUNPASCAUD M CHAU F GARRY L FARINOTTI R DEROUIN F GIRARD PM
Citation: M. Brunpascaud et al., ALTERED TRIMETHOPRIM-SULFAMETHOXAZOLE RATIOS FOR PROPHYLAXIS AND TREATMENT OF TOXOPLASMA-GONDII AND PNEUMOCYSTIS-CARINII DUAL INFECTIONS INRAT MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 201-207

Authors: BRUNPASCAUD M CHAU F RAJAGOPALANLEVASSEUR P DEROUIN F GIRARD JM
Citation: M. Brunpascaud et al., EVALUATION OF THE ACTIVITIES OF RIFABUTIN COMBINED WITH ATOVAQUONE ORLOW-DOSE OF COTRIMOXAZOLE FOR PREVENTION OF PNEUMOCYSTOSIS AND TOXOPLASMOSIS IN A DUAL INFECTION RAT MODEL, The Journal of eukaryotic microbiology, 43(5), 1996, pp. 14-15

Authors: SULAHIAN A TABOURET M RIBAUD P SARFATI J GLUCKMAN E LATGE JP DEROUIN F
Citation: A. Sulahian et al., COMPARISON OF AN ENZYME-IMMUNOASSAY AND LATEX AGGLUTINATION-TEST FOR DETECTION OF GALACTOMANNAN IN THE DIAGNOSIS OF INVASIVE ASPERGILLOSIS, European journal of clinical microbiology & infectious diseases, 15(2), 1996, pp. 139-145

Authors: SUMYUEN MH GARIN YJF DEROUIN F
Citation: Mh. Sumyuen et al., EFFECT OF IMMUNOSUPPRESSIVE DRUG REGIMENS ON ACUTE AND CHRONIC MURINETOXOPLASMOSIS, Parasitology research, 82(8), 1996, pp. 681-686
Risultati: 1-25 | 26-50 | 51-67